OU Health Launches Oklahoma's First AI-Powered Adaptive Radiation Therapy System
核心洞察
OU Health Stephenson Cancer Center (搜索) becomes the first in Oklahoma to deploy the Varian Ethos (搜索) system, an AI-powered adaptive radiation therapy platform that adjusts treatment plans in real time.
The $3 million system uses artificial intelligence and advanced imaging to map tumor changes—such as movement, shrinkage, or shape shifts—and adapt radiation dosing accordingly on the day of treatment.
Dr. Tyler Gunter, radiation oncologist, noted the technology can compress treatment timelines, with what once took five weeks potentially being completed in five days.
OU Health Stephenson Cancer Center (搜索) is set to launch Oklahoma's first artificial intelligence-powered adaptive radiation therapy system, marking a significant advancement in the state's cancer (搜索) treatment capabilities. The Varian Ethos (搜索) system, a $3 million machine, began operations on Monday and represents a departure from traditional radiation therapy, which relies on static treatment plans built from CT scans taken days or weeks earlier.
The new system uses artificial intelligence and advanced imaging to adjust radiation treatment plans in real time based on the patient's anatomy on the day of treatment. "Now the AI is going to be working on adjusting our targets and normal tissues," said Dr. Tyler Gunter, radiation oncologist at OU Health Stephenson Cancer Center (搜索).
Real-Time Adaptation to Anatomical Changes
Traditional radiation therapy is typically built around a single, static treatment plan. However, tumors can move and a patient's anatomy can change throughout the course of care, meaning treatment needs can evolve from day to day. The Ethos system addresses this challenge by scanning the patient while the oncology team monitors from outside using multiple cameras. The AI-powered technology maps changes in the tumor—such as movement, shrinkage, or changes in shape—and adjusts the radiation dose accordingly.
"The Ethos system allows us to, on the fly, adapt that radiation plan," Gunter explained. "Allowing us to deliver the radiation therapy more precisely."
Gunter acknowledged the clinical realities that make adaptive therapy valuable. "We do run into some cases where there is significant change in tumor configuration or there is progression of disease unfortunately," he said.
AI as a Clinical Tool, Not a Decision-Maker
Gunter emphasized that artificial intelligence does not make clinical decisions but serves as a tool to help the oncology team deliver complex treatments more quickly and with greater precision. The system is designed to combine precision medicine with AI-guided adaptive therapy and streamlined workflows, with the goal of improving both treatment accuracy and the patient experience.
The impact on treatment timelines could be substantial. "What may have taken five weeks to treat may now take five days," Gunter said.
Strategic Partnership Enables Technology Access
The technology was made possible through OU Health's 10-year Value Partnership with Siemens Healthineers (搜索), a collaboration focused on expanding access to advanced technology, strengthening clinical capabilities, and improving health outcomes for patients across Oklahoma. The Varian Ethos (搜索) system is described as the first of its kind in the state.
The system is intended to advance patient-centered cancer (搜索) care by tailoring radiation delivery to each patient's anatomy on the day of treatment, representing a shift toward more personalized and precise radiation oncology.